kate-kindness-01

Our mission is to find safer, smarter and more effective treatments for children with cancer.

Welcome to Kate Amato Foundation

Cancer is the leading cause of death by disease in children. For those who survive, the side effects of treatment can cause severe long-term health problems. To honor Kate’s life, and continue the fight for other children, Kate Amato Foundation is dedicated to finding safer, smarter and more effective treatments for children with cancer. Our vision is to fund innovative pediatric cancer research that accelerates the pace of progress and saves young lives.

donate-outlined

Donate

Help Kate Amato Foundation fund Pediatric Cancer Research. 

fundraise-outlined

Fundraise

Start a fundraising event for Kate Amato Foundation click here.

volunteer-outlined

Volunteer

Volunteer your time and talents at one of our fundraising events.

Did You Know?

chilhood-cancer-diagnosis
more than
children receive treatment for cancer each year
child-cancer-treatment
only
cancer treatments have been specifically developed and approved for children in the last 20 years
child-survival-rate
1 out of
children with cancer will not survive

Recently Funded

Elucidating Molecular Mechanisms Underlying Exceptionally Wide Therapeutic Window for Small Molecule Allosteric Activators of Protein Phosphatase 2A

Ken Morita, MD, PhD

Dana-Farber Cancer Institute, Harvard Medical School

$50,000

T Cell Acute Lymphoblastic Leukemia
Selective cytotoxic effects of CDK12 inhibition on metastatic osteosarcoma cells

Matthew Harlow, PhD

Dana-Farber Cancer Institute, Harvard Medical School

$25,000

Metastatic Osteosarcoma (OS)
Understanding the Role of MYCN-Driven FA Update to LIPID Metabolism and Tumor Growth to Identify a Targeted Approach for High-Risk MYCN-Amplified Neuroblastoma

Ling Tao, PhD

Texas Children’s Cancer Center, Baylor College of Medicine

$25,000

High-Risk MYCN-Amplified Neuroblastoma